October 16, 2021 09:12 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Kashmir: Two terrorists behind targetted killings of civilian, cop shot dead | US to reopen land and air borders to fully vaccinated foreign visitors from Nov 8 | Navjot Sidhu meets Rahul Gandhi amid Punjab Congress turmoil | Army officer, jawan critically injured in counter terror op in J&K's poonch district | 'Will follow whatever Gandhis decide:' Navjot Sidhu after meeting senior Cong leaders amid Punjab crisis

Over two-thirds people in Nepal have COVID-19 antibodies: Survey

Kathmandu/UNI/XINHUA: Over two-thirds of Nepal's population has developed antibodies against COVID-19, as shown by a nationwide survey conducted by the Ministry of Health and Population (MoHP).

Antibodies to SARS-CoV-2 remain stable, or even increase, seven months after infection: Study

Barcelona: The levels of IgG antibodies against SARS-CoV-2 Spike protein remain stable, or even increase, seven months after infection, according to a follow-up study in a cohort of healthcare workers coordinated by the Barcelona Institute for Global Health (ISGlobal), an institution supported by “la Caixa” Foundation, in collaboration with the Hospital Clinic of Barcelona.

Chinese Sinopharm COVID-19 vaccine falls short in producing antibodies: Study

Budapest: A Hungarian study has found China's Sinopharm vaccines failed to  produce sufficient antibodies in a quarter of elderly people who were voluntarily tested in Budapest, media reports said.

India's COVAXIN generates antibodies that effectively neutralize Alpha and Delta variants of coronavirus, says US health research institute

Washington: A study conducted by  the US' National Institute of Health has said India's COVAXIN, which was developed by Bharat Biotech in collaboration with the Indian Council of Medical Research, neutralises both Alpha and Delta variants of COVID-19.

Another sero survey finds over 56 percent residents of Delhi have developed antibodies against Coronavirus

New Delhi: A  fifth serological survey conducted in New Delhi has found that more than 56 percent of residents in Delhi have been exposed to the coronavirus and they have developed antibodies for the infection, government revealed on Tuesday.

Pre-existing coronavirus antibodies could help protect children against new pandemic strain: Study

London: Researchers at the Francis Crick Institute and University College London have found that some antibodies, created by the immune system during infection with common cold coronaviruses, can also target SARS-CoV-2 and may confer a degree of protection against the new viral strain.

Israeli researchers developing antibody cocktail to treat, prevent COVID-19

Jerusalem/Xinhua: Israeli researchers have been developing an antibody cocktail to treat and prevent COVID-19, Tel Aviv University (TAU) in central Israel said on Sunday.

Global coronavirus death toll crosses 2 lakhs, WHO says antibody response will provide some relief from reinfection

Geneva/IBNS: Hours after the World Health Organization claimed that recovery from coronavirus might not shield a person from reinfection, the global health body has clarified that people who are infected with COVID-19 will develop an antibody response that will provide some level of protection.

Human antibody discovery could save lives from fungal killer: Study

London, Dec 12 (IBNS): A new way to diagnose, treat and protect against stealth fungal infections that claim more than 1.5 million lives per year worldwide has been moved a step closer, according to research published in Nature Communications.